STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

2.50
Hdl Handle:
http://hdl.handle.net/10146/232315
Title:
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.
Authors:
Gallo, Valentina; Egger, Matthias; McCormack, Valerie; Farmer, Peter B.; Ioannidis, John P. A.; Kirsch-Volders, Micheline; Matullo, Giuseppe; Phillips, David H.; Schoket, Bernadette; Stromberg, Ulf; Vermeulen, Roel; Wild, Christopher; Porta, Miquel; Vineis, Paolo
Abstract:
Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agents and the body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.
Citation:
Prev. Med. 2011, 53 (6):377-387; Erratum in: Prev. Med. 2012;54(5):367.
Journal:
Preventive Medicine
Issue Date:
Dec-2011
URI:
http://hdl.handle.net/10146/232315
DOI:
10.1016/j.ypmed.2011.08.007
PubMed ID:
22029945
Additional Links:
http://www.sciencedirect.com/science/article/pii/S0091743511002969
Type:
Article
Language:
en
Description:
This article is being simultaneously published in 2011 in PLoS Medicine, Journal of Clinical Epidemiology, Preventive Medicine, Mutagenesis, Journal of Epidemiology and Community Health, European Journal of Epidemiology and European Journal of Clinical Investigation. Reproduced by permission of the authors. The authors jointly hold the copyright of this article.
ISSN:
1096-0260
Sponsors:
This paper is part of an activity sponsored by the ECNIS network (EC grant FOOD-CT-2005-513943) (www.ecnis.org). We acknowledge the contribution of Dan Segerbäck, Jim Vaught, Soterios Kyrtopoulos, Franz Oesch, Jelle Vlaanderen, and Jouni Jaakkola to the discussion of an earlier version of the paper.
Appears in Collections:
Articles

Full metadata record

DC FieldValue Language
dc.contributor.authorGallo, Valentinaen_GB
dc.contributor.authorEgger, Matthiasen_GB
dc.contributor.authorMcCormack, Valerieen_GB
dc.contributor.authorFarmer, Peter B.en_GB
dc.contributor.authorIoannidis, John P. A.en_GB
dc.contributor.authorKirsch-Volders, Michelineen_GB
dc.contributor.authorMatullo, Giuseppeen_GB
dc.contributor.authorPhillips, David H.en_GB
dc.contributor.authorSchoket, Bernadetteen_GB
dc.contributor.authorStromberg, Ulfen_GB
dc.contributor.authorVermeulen, Roelen_GB
dc.contributor.authorWild, Christopheren_GB
dc.contributor.authorPorta, Miquelen_GB
dc.contributor.authorVineis, Paoloen_GB
dc.date.accessioned2012-07-06T09:08:30Z-
dc.date.available2012-07-06T09:08:30Z-
dc.date.issued2011-12-
dc.identifier.citationPrev. Med. 2011, 53 (6):377-387en_GB
dc.identifier.citationErratum in: Prev. Med. 2012;54(5):367.-
dc.identifier.issn1096-0260-
dc.identifier.pmid22029945-
dc.identifier.doi10.1016/j.ypmed.2011.08.007-
dc.identifier.urihttp://hdl.handle.net/10146/232315-
dc.descriptionThis article is being simultaneously published in 2011 in PLoS Medicine, Journal of Clinical Epidemiology, Preventive Medicine, Mutagenesis, Journal of Epidemiology and Community Health, European Journal of Epidemiology and European Journal of Clinical Investigation. Reproduced by permission of the authors. The authors jointly hold the copyright of this article.en_GB
dc.description.abstractAdvances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agents and the body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.en_GB
dc.description.sponsorshipThis paper is part of an activity sponsored by the ECNIS network (EC grant FOOD-CT-2005-513943) (www.ecnis.org). We acknowledge the contribution of Dan Segerbäck, Jim Vaught, Soterios Kyrtopoulos, Franz Oesch, Jelle Vlaanderen, and Jouni Jaakkola to the discussion of an earlier version of the paper.en_GB
dc.language.isoenen
dc.relation.urlhttp://www.sciencedirect.com/science/article/pii/S0091743511002969en_GB
dc.rightsArchived with thanks to Preventive medicineen_GB
dc.subjectBiological markersen_GB
dc.subjectHumansen_GB
dc.subjectMolecular epidemiologyen_GB
dc.subjectReference standardsen_GB
dc.subjectCohort Studiesen_GB
dc.subjectCross-Sectional Studiesen_GB
dc.subject.meshBiological Markers-
dc.subject.meshChecklist-
dc.subject.meshEpidemiologic Studies-
dc.subject.meshHumans-
dc.subject.meshMolecular Epidemiology-
dc.subject.meshObservation-
dc.titleSTrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.en
dc.typeArticleen
dc.identifier.journalPreventive Medicineen_GB

Related articles on PubMed

All Items in ECNIS-NIOM are protected by copyright, with all rights reserved, unless otherwise indicated.